Table of Content



1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 BRIC Generics
2.1. Industry Outlook

3 Generics in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in China
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Generics in India
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Generics in Russia
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Company Profiles
11.1. Sanofi SA
11.2. EMS SA
11.3. Ache Laboratorios Farmaceuticos SA
11.4. Eurofarma Laboratorios SA
11.5. Teva Pharmaceutical Industries Limited
11.6. Viatris Inc.
11.7. Pfizer Inc.
11.8. Grand Pharmaceutical Group Limited
11.9. Sun Pharmaceutical Industries Ltd
11.10. Lupin Ltd
11.11. Aurobindo Pharma Ltd
11.12. Cipla Limited
11.13. Krka, d. d., Novo mesto
11.14. Abbott Laboratories

12 Appendix
12.1. Methodology
12.2. About MarketLine



List of Figures

List of Figures
Figure 1: BRIC generics industry, revenue($m), 2018-27
Figure 2: BRIC generics industry, revenue($m), 2018-22
Figure 3: BRIC generics industry, revenue($m), 2022-27
Figure 4: Brazil generics market value: $ million, 2017-22
Figure 5: Brazil generics market volume: %, 2017-22
Figure 6: Brazil generics market geography segmentation: % share, by value, 2022
Figure 7: Brazil generics market value forecast: $ million, 2022-27
Figure 8: Brazil generics market volume forecast: %, 2022-27
Figure 9: Forces driving competition in the generics market in Brazil, 2022
Figure 10: Drivers of buyer power in the generics market in Brazil, 2022
Figure 11: Drivers of supplier power in the generics market in Brazil, 2022
Figure 12: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2022
Figure 13: Factors influencing the threat of substitutes in the generics market in Brazil, 2022
Figure 14: Drivers of degree of rivalry in the generics market in Brazil, 2022
Figure 15: China generics market value: $ million, 2017-22
Figure 16: China generics market volume: %, 2017-22
Figure 17: China generics market geography segmentation: % share, by value, 2022
Figure 18: China generics market value forecast: $ million, 2022-27
Figure 19: China generics market volume forecast: %, 2022-27
Figure 20: Forces driving competition in the generics market in China, 2022
Figure 21: Drivers of buyer power in the generics market in China, 2022
Figure 22: Drivers of supplier power in the generics market in China, 2022
Figure 23: Factors influencing the likelihood of new entrants in the generics market in China, 2022
Figure 24: Factors influencing the threat of substitutes in the generics market in China, 2022
Figure 25: Drivers of degree of rivalry in the generics market in China, 2022
Figure 26: India generics market value: $ million, 2017-22
Figure 27: India generics market volume: %, 2017-22
Figure 28: India generics market geography segmentation: % share, by value, 2022
Figure 29: India generics market value forecast: $ million, 2022-27
Figure 30: India generics market volume forecast: %, 2022-27
Figure 31: Forces driving competition in the generics market in India, 2022
Figure 32: Drivers of buyer power in the generics market in India, 2022
Figure 33: Drivers of supplier power in the generics market in India, 2022
Figure 34: Factors influencing the likelihood of new entrants in the generics market in India, 2022
Figure 35: Factors influencing the threat of substitutes in the generics market in India, 2022
Figure 36: Drivers of degree of rivalry in the generics market in India, 2022
Figure 37: Russia generics market value: $ million, 2017-22
Figure 38: Russia generics market volume: %, 2017-22
Figure 39: Russia generics market geography segmentation: % share, by value, 2022
Figure 40: Russia generics market value forecast: $ million, 2022-27
Figure 41: Russia generics market volume forecast: %, 2022-27
Figure 42: Forces driving competition in the generics market in Russia, 2022
Figure 43: Drivers of buyer power in the generics market in Russia, 2022
Figure 44: Drivers of supplier power in the generics market in Russia, 2022
Figure 45: Factors influencing the likelihood of new entrants in the generics market in Russia, 2022
Figure 46: Factors influencing the threat of substitutes in the generics market in Russia, 2022
Figure 47: Drivers of degree of rivalry in the generics market in Russia, 2022

List of Tables

List of Tables
Table 1: BRIC generics industry, revenue($m), 2018-27
Table 2: BRIC generics industry, revenue($m), 2018-22
Table 3: BRIC generics industry, revenue($m), 2022-27
Table 4: Brazil generics market value: $ million, 2017-22
Table 5: Brazil generics market volume: %, 2017-22
Table 6: Brazil generics market geography segmentation: $ million, 2022
Table 7: Brazil generics market value forecast: $ million, 2022-27
Table 8: Brazil generics market volume forecast: %, 2022-27
Table 9: Brazil size of population (million), 2018-22
Table 10: Brazil gdp (constant 2005 prices, $ billion), 2018-22
Table 11: Brazil gdp (current prices, $ billion), 2018-22
Table 12: Brazil inflation, 2018-22
Table 13: Brazil consumer price index (absolute), 2018-22
Table 14: Brazil exchange rate, 2018-22
Table 15: China generics market value: $ million, 2017-22
Table 16: China generics market volume: %, 2017-22
Table 17: China generics market geography segmentation: $ million, 2022
Table 18: China generics market value forecast: $ million, 2022-27
Table 19: China generics market volume forecast: %, 2022-27
Table 20: China size of population (million), 2018-22
Table 21: China gdp (constant 2005 prices, $ billion), 2018-22
Table 22: China gdp (current prices, $ billion), 2018-22
Table 23: China inflation, 2018-22
Table 24: China consumer price index (absolute), 2018-22
Table 25: China exchange rate, 2018-22
Table 26: India generics market value: $ million, 2017-22
Table 27: India generics market volume: %, 2017-22
Table 28: India generics market geography segmentation: $ million, 2022
Table 29: India generics market value forecast: $ million, 2022-27
Table 30: India generics market volume forecast: %, 2022-27
Table 31: India size of population (million), 2018-22
Table 32: India gdp (constant 2005 prices, $ billion), 2018-22
Table 33: India gdp (current prices, $ billion), 2018-22
Table 34: India inflation, 2018-22
Table 35: India consumer price index (absolute), 2018-22
Table 36: India exchange rate, 2018-22
Table 37: Russia generics market value: $ million, 2017-22
Table 38: Russia generics market volume: %, 2017-22
Table 39: Russia generics market geography segmentation: $ million, 2022
Table 40: Russia generics market value forecast: $ million, 2022-27
Table 41: Russia generics market volume forecast: %, 2022-27
Table 42: Russia size of population (million), 2018-22
Table 43: Russia gdp (constant 2005 prices, $ billion), 2018-22
Table 44: Russia gdp (current prices, $ billion), 2018-22
Table 45: Russia inflation, 2018-22
Table 46: Russia consumer price index (absolute), 2018-22
Table 47: Russia exchange rate, 2018-22
Table 48: Sanofi SA: key facts
Table 49: Sanofi SA: Annual Financial Ratios
Table 50: Sanofi SA: Key Employees
Table 51: Sanofi SA: Key Employees Continued
Table 52: EMS SA: key facts
Table 53: EMS SA: Key Employees
Table 54: Ache Laboratorios Farmaceuticos SA: key facts
Table 55: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 56: Eurofarma Laboratorios SA: key facts
Table 57: Eurofarma Laboratorios SA: Key Employees
Table 58: Teva Pharmaceutical Industries Limited: key facts
Table 59: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 60: Teva Pharmaceutical Industries Limited: Key Employees
Table 61: Viatris Inc.: key facts
Table 62: Viatris Inc.: Annual Financial Ratios
Table 63: Viatris Inc.: Key Employees
Table 64: Viatris Inc.: Key Employees Continued
Table 65: Pfizer Inc.: key facts
Table 66: Pfizer Inc.: Annual Financial Ratios
Table 67: Pfizer Inc.: Key Employees
Table 68: Pfizer Inc.: Key Employees Continued
Table 69: Grand Pharmaceutical Group Limited: key facts
Table 70: Grand Pharmaceutical Group Limited: Annual Financial Ratios
Table 71: Grand Pharmaceutical Group Limited: Key Employees
Table 72: Sun Pharmaceutical Industries Ltd: key facts
Table 73: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 74: Sun Pharmaceutical Industries Ltd: Key Employees
Table 75: Lupin Ltd: key facts
Table 76: Lupin Ltd: Annual Financial Ratios
Table 77: Lupin Ltd: Key Employees
Table 78: Aurobindo Pharma Ltd: key facts
Table 79: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 80: Aurobindo Pharma Ltd: Key Employees
Table 81: Cipla Limited: key facts
Table 82: Cipla Limited: Annual Financial Ratios
Table 83: Cipla Limited: Key Employees
Table 84: Krka, d. d., Novo mesto: key facts
Table 85: Krka, d. d., Novo mesto: Annual Financial Ratios
Table 86: Krka, d. d., Novo mesto: Key Employees
Table 87: Krka, d. d., Novo mesto: Key Employees Continued
Table 88: Abbott Laboratories: key facts
Table 89: Abbott Laboratories: Annual Financial Ratios
Table 90: Abbott Laboratories: Key Employees
Table 91: Abbott Laboratories: Key Employees Continued